"The Lackluster Debut" features three executives from Medicamen Pharmaceutical persuading the Director Alan Johnson of the The National Institute of Allergy and Infectious Diseases to mandate their newest drug for public use to combat a newly-infectious disease. The executives seek the mandate because the American public isn't taking the drug as the company hoped for. Director Johnson knows what the pharmaceutical company wants his department to do is wrong, but he knows if he can't back down from their request. Doing so would bode bad for his career and the department's reputation. So he battles the predicament before him: Give into Medicamen and force the public to take their drug, or tell the public about the company's plan?